Skip to content
Open access

Tcf4 CTG Repeat Expansion Induces RNA Toxicity and MBNL-Associated Splicing Dysregulation in a Mouse Model of Fuchs Endothelial Corneal Dystrophy

Sep 2026 · Investigative Ophthalmology and Visual Science · Vol 67 · 0 citations · 51 references
Medicine

Abstract

Purpose To determine whether a Tcf4 CTG repeat knock-in mouse model of Fuchs endothelial corneal dystrophy (FECD) recapitulates molecular features of repeat RNA toxicity and MBNL-associated splicing dysregulation in corneal endothelial cells in vivo. Methods Corneal endothelial tissues from 20-, 40-, and 60-week-old wild-type and Tcf4(CTG)100/(CTG)100 mice were examined by contact specular microscopy and CUG-repeat RNA FISH with MBNL1 immunostaining. At 60 weeks, we used RT-PCR, quantitative PCR, Western blotting, and RNA-Seq analysis to assess Mbnl autoregulatory splicing, genome-wide alternative splicing, RNA-binding protein motif enrichment, and Tcf4 isoform composition; selected splicing events were compared with human FECD data. Results Tcf4 (CTG)100/(CTG)100 mice showed neither obvious guttae-like abnormalities nor nuclear RNA foci at 20 weeks; both were detected at 40 and 60 weeks, whereas wild-type mice showed neither at any age. Foci-positive nuclei and RNA foci–MBNL1 colocalization did not differ between 40 and 60 weeks. Although Mbnl1 and Mbnl2 transcript levels and MBNL1 and MBNL2 protein levels were unchanged, Mbnl2 exon 6 inclusion was reduced. RNA-Seq reanalysis identified 645 differential alternative splicing events, predominantly skipped exons, with MBNL1 motif enrichment among events with increased exon skipping. Representative MBNL-regulated events were only partially conserved between the mouse model and human FECD. Total Tcf4 expression was unchanged, whereas Tcf4-225 was selectively upregulated. Conclusions This model provides in vivo evidence that Tcf4 CTG repeat expansion can induce molecular hallmarks of repeat RNA toxicity and downstream MBNL-associated splicing dysregulation, together with selective Tcf4 isoform alteration. It offers an in vivo platform for mechanistic and therapeutic studies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.